Man Charged With $4.7M Sanofi Insider Trading Scheme
A Swiss businessman has been charged in the U.S. with insider trading ahead of Sanofi SA's acquisition of Bioverativ Inc. last year in an alleged get-rich-quick scheme that netted cash and...To view the full article, register now.
Already a subscriber? Click here to view full article